KoKo Medical
Malvern, US · Founded 2020 · Delaware corporation
Founders & leadership
JK
Jason KeiserExecutive
MW
Michael WallaceExecutive
SG
Skott GreenhalghNamed on SEC filing
Board
MR
Megan RosengartenBoard director
MT
Matthew TopliffBoard director
TN
Tony NataleBoard director
WD
William DaiBoard director
Reported raises · per SEC filings
Form D private placements$26.6M disclosed across 5 rounds · 2020–2026
▶$8MraisedFeb 2026 · 29 investors · Other Health CareRule 506(b)
▶$8MraisedFeb 2026 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason KeiserExecutive Officer
- Megan RosengartenDirector
- Skott GreenhalghExecutive Officer, Director
- Matthew TopliffDirector
- Tony NataleDirector
- William DaiDirector
- Michael WallaceExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $8M
- Proceeds to insiders
- $1.8M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedDec 2023 · 33 investors · Other Health CareRule 506(b)
▶$6MraisedDec 2023 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael WallaceExecutive Officer, Director
- William DaiDirector
- Skott GreenhalghExecutive Officer, Director
- Megan RosengartenDirector
- Tony NataleDirector
- Jason KeiserExecutive Officer
- Matthew TopliffDirector
- Offering amount
- $12M
- Amount sold
- $6M
- Proceeds to insiders
- $2.2M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$8.7MraisedJan 2023 · 37 investors · Other Health CareRule 506(b)
▶$8.7MraisedJan 2023 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael WallaceExecutive Officer, Director
- Skott GreenhalghExecutive Officer, Director
- Matthew TopliffDirector
- William DaiDirector
- Jason KeiserExecutive Officer
- Offering amount
- $12.5M
- Amount sold
- $8.7M
- Proceeds to insiders
- $210K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.5MraisedNov 2021 · 28 investors · Other Health CareRule 506(b)
▶$2.5MraisedNov 2021 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew TopliffDirector
- Jason KeiserExecutive Officer
- Michael WallaceExecutive Officer, Director, Promoter
- Skott GreenhalghExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $2.5M
- Proceeds to insiders
- $236K
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.4MraisedMar 2020 · 11 investors · Other Health CareRule 506(b)
▶$1.4MraisedMar 2020 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Skott GreenhalghExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.4M
- Proceeds to insiders
- $150K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has KoKo Medical raised?
- KoKo Medical has disclosed $26.6M raised across 5 rounds.
- Where is KoKo Medical headquartered?
- KoKo Medical is headquartered in Malvern, US.